Atlas FDA

ARCHITECT ANTI-HCV

FDA premarket approval P050042/S027 · decided 2013-11-26

Approval details

PMA number
P050042
Supplement
S027
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
ARCHITECT ANTI-HCV
Generic name
Assay, enzyme linked immunosorbent, hepatitis c virus
Applicant
Abbott Laboratories, Inc.
Date received
2013-10-28
Decision date
2013-11-26
Days to decision
29 days
Decision code
OK30
Product code
MZO
Advisory committee
Microbiology
Expedited review
No
Location
Abbott Park, IL
Statement
REPLACEMENT OF A QUALITY CONTROL TEST WITH A NEW QUALITY CONTROL TEST FOR AN INCOMING RAW MATERIAL.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
ARCHITECT IVALPROIC ACID REAGENTS AND ARCHITECT IVALPROIC ACID CALIBRATORS, MODELS 1P35, 1P35 (K090358)Abbott Laboratories, Inc.2009-08-06
CREATININE (K061193)Abbott Laboratories, Inc.2006-06-23
PRECISION XTRA PLUS OR OPTIUM PLUS, BLOOD GLUCOSE TEST STRIPS (K051213)Abbott Laboratories, Inc.2005-05-27
FOX PLUS PTA CATHETER (K040954)Abbott Laboratories, Inc.2004-05-11
AXSYM CYCLOSPORINE (K040761)Abbott Laboratories, Inc.2004-04-30
GEMSTAR INFUSION PUMP SYSTEM, 7 THERAPY, 6 THERAPY & PAIN MANAGEMENT (K023062)Abbott Laboratories, Inc.2002-09-30